Skip to main content
Log in

Treatment of vasculitic leg ulcers in connective tissue disease with Iloprost

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

Leg ulcers are a recognised manifestation of cutaneous vasculitis in connective tissue diseases (CTDs) including rheumatoid arthritis (RA). Iloprost a stable prostacyclin analogue has been sucessfully used to treat Raynaud's phenomenon and digital ulcers associated with CTD's. Our aim was to assess iloprost in the treatment of vasculitic leg ulcers in CTD. In this paper we describe eight cases of vasculitic leg ulceration in association with RA and CTD, treated with intravenous iloprost. The iloprost was administered for 6–8 hours daily and continued for 21–28 days. Immunosuppressive therapy was required in three patients with severe necrotising vasculitis (RAnv). Complete ulcer healing was achieved in four patients within 6 weeks of commencing therapy while rapid improvement occurred in the other four patients. This suggests that iloprost may be useful as an adjunct to therapy for vasculitic leg ulcers. A double-blind placebo controlled study of iloprost therapy for RA leg ulcers is under way.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wilkinson, M., Kirk, J. Leg ulcers complicating rheumatoid arthritis. Scott Med J 1965, 10, 175–182.

    PubMed  Google Scholar 

  2. Belch, J.J.F., Drury, J.K., Capell, H. et al. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome — a double-blind controlled trial. Lancet 1983, 8320, 313–315.

    Google Scholar 

  3. Yardumian, D.A., Isenberg, D.A., Rustin, M. et al. Suecessful treatment of Raynaud's syndrome with iloprost, a chemically stable prostacyclin analogue. Br J Rheumatol 1988, 27, 222–226.

    Google Scholar 

  4. McHugh, N.J., Scuka, M., Watson, H. et al. Infusion of iloprost, a prostacyclin analogue, for the treatment of raynaud's phenomenon in systemic sclerosis. Ann Rheum Dis 1988, 47, 43–47.

    PubMed  Google Scholar 

  5. Arnett, F.C., Edworthy, S., Block, D.A. et al. The 1987 revised ARA criteria for rheumatoid arthritis. Arthritis Rheum 1987, 30, S17.

    Google Scholar 

  6. Belch, J.J.F., Sanibadi, A., Dickson, R., Sturrock, R.D., Forbes, C.D. Effect of iloprost (ZK 36374) on white cell behavior. In: Prostacyclin and its Stable Analogue Iloprost. Eds.: Gryglewski, R.J., Stock, G. Springer Verlag, Berlin 1987, 97–102.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Veale, D.J., Muir, A.H., Morley, K.D. et al. Treatment of vasculitic leg ulcers in connective tissue disease with Iloprost. Clin Rheumatol 14, 187–190 (1995). https://doi.org/10.1007/BF02214941

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02214941

Key words

Navigation